Alpha Tau Medical Ltd (DRTS) Financials

DRTS Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 108.8 million 39.4 million
Dec. 31, 2025 106.6 million 29.5 million
Sept. 30, 2025 104.7 million 27.1 million
June 30, 2025 111.0 million 24.3 million

DRTS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 ? ?
Dec. 31, 2025 -32.8 million ?
Sept. 30, 2025 ? -5.3 million
June 30, 2025 ? 5.3 million

DRTS Net Income

No data available :(

DRTS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 80.2 million 6.4 million 6.7 million
Dec. 31, 2025 76.9 million 6.4 million 6.2 million
Sept. 30, 2025 72.2 million 6.2 million 7.3 million
June 30, 2025 79.7 million 6.0 million 7.3 million

DRTS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 89.7 million
Dec. 31, 2025 85.7 million
Sept. 30, 2025 85.3 million
June 30, 2025 80.4 million

DRTS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 11.0 million 2.3 million 241000
Dec. 31, 2025 6.1 million 9.6 million 3.0 million 452000
Sept. 30, 2025 - 8.3 million 2.4 million 490000
June 30, 2025 - 7.0 million 2.6 million 459000

DRTS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2025 - -
June 30, 2025 - -

DRTS

Price: $12.50

52 week price:
2.87
13.58

Earnings Per Share: -0.67 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 1.2 billion

Links: